483 Cangene BioPharma Jun 2018

483 Cangene BioPharma Jun 2018

Debra Emerson FDA$119.00 - Available Now

FDA investigators audited the Cangene BioPharma - Baltimore, MD, United States facility and issued inspectional observations (via FDA 483) on 13 Jun 2018.

Product details

  • Category: Biologics
  • Inspection end: 13 Jun 2018
  • Location: Baltimore, United States
  • FEI: 1000512361
Add To Cart